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GO

:   Gene ontology

KEGG

:   kyoto Encyclopedia of Genes and Genomes

lncRNA

:   long noncoding RNAs

PDA

:   pancreatic ductal adenocarcinoma

qPCR

:   quantitative reverse transcription polymerase chain reaction

WGCNA

:   weighted gene coexpression network analysis

1. INTRODUCTION {#jcp29255-sec-0010}
===============

Pancreatic ductal adenocarcinoma (PDA) accounts for 95% of pancreatic cancers (Kuroczycki‐Saniutycz et al., [2017](#jcp29255-bib-0013){ref-type="ref"}). About 230,000 new PDA cases are diagnosed worldwide annually (Kuroczycki‐Saniutycz et al., [2017](#jcp29255-bib-0013){ref-type="ref"}; Malats, Molina‐Montes, & La Vecchia, [2017](#jcp29255-bib-0018){ref-type="ref"}). Unfortunately, compared with other malignancies, patients with PDA have the worst 5‐year survival rates (Ariake et al., [2017](#jcp29255-bib-0001){ref-type="ref"}; Kuroczycki‐Saniutycz et al., [2017](#jcp29255-bib-0013){ref-type="ref"}). Delayed diagnosis and lack of effective chemotherapy have been reported as the reasons for such poor rates (Macchini et al., [2019](#jcp29255-bib-0017){ref-type="ref"}; Sun et al., [2018](#jcp29255-bib-0020){ref-type="ref"}; Tiriac, Plenker, Baker, & Tuveson, [2019](#jcp29255-bib-0021){ref-type="ref"}). Thus, understanding the potential molecular mechanism underlying PDA initiation and progression has become increasingly important to enable drug development and diagnostic‐marker investigations.

One of the earliest and most common genetic alterations is the activation of the MEK/ERK pathway signaling (Gysin, Paquette, & McMahon, [2012](#jcp29255-bib-0007){ref-type="ref"}; Kinsey et al., [2019](#jcp29255-bib-0012){ref-type="ref"}). Previous studies have indicated that the MEK/ERK pathway signaling plays a vital role in the progression of PDA and can become a therapeutic target (Vaseva et al., [2018](#jcp29255-bib-0022){ref-type="ref"}). Activation of MEK1/ERK1/2 signaling enhances proliferation through apoptosis inhibition (Wang, Zhao et al., [2018](#jcp29255-bib-0023){ref-type="ref"}). The inhibition of MEK signaling reportedly reduces pancreatic cancer metastasis in mouse models (Gu et al., [2018](#jcp29255-bib-0006){ref-type="ref"}). A new ERK‐specific inhibitor, ulixertinib, has demonstrated an antitumor effect on PDA (Jiang et al., [2018](#jcp29255-bib-0011){ref-type="ref"}). Accordingly, further understanding the role of the MEK/ERK regulatory network in PDA has become a research hotspot.

Long noncoding RNAs (lncRNAs) are a vital group of noncoding RNA molecules greater than 200 nucleotides (Dong et al., [2019](#jcp29255-bib-0004){ref-type="ref"}; Yu et al., [2019](#jcp29255-bib-0030){ref-type="ref"}). Previously, lncRNAs have been regarded as noises of genetic materials (Xiu et al., [2019](#jcp29255-bib-0028){ref-type="ref"}). However, many studies have proven that lncRNAs play important roles in PDA development (Huang et al., [2018](#jcp29255-bib-0009){ref-type="ref"}). lncRNA CUDR enhances malignant phenotypes by activating ERK signaling in PDA (Liang et al., [2018](#jcp29255-bib-0014){ref-type="ref"}). lncRNA NONHSAT105177 induced by melittin suppresses proliferation and migration in PDA (Wang, Li et al., [2018](#jcp29255-bib-0024){ref-type="ref"}).

The identification of novel lncRNA--mRNA networks can contribute to understanding the potential molecular mechanism underlying oncogenesis and tumor development. Through microarray analyses, a lncRNA--mRNA coexpression network has been constructed in pituitary adenoma. Then, 130 specific lncRNA--mRNA coexpression relationships have been identified, contributing to the investigation of pituitary‐adenoma pathogenesis (Xing et al., [2019](#jcp29255-bib-0027){ref-type="ref"}).

However, genome‐wide profiles of lncRNA--mRNA networks in MEK/ERK pathway signaling in PDA are lacking. GSE45765 is expression profiling by using arrays from PDA cells with and without MEK1/2 inhibitor. Thus, in the present work, we downloaded GSE45765 from the GEO database. We then constructed mRNA and lncRNA coexpression networks based on weighted gene coexpression network analysis (WGCNA) and identified 10 modules. Subsequently, function and pathway enrichment analysis were performed through Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Kaplan--Meier survival analysis of differently expressed mRNAs and lncRNAs were performed based on The Cancer Genome Atlas (TCGA). Finally, PDA cell lines and tissues were used to validate the analysis results.

2. MATERIALS AND METHODS {#jcp29255-sec-0020}
========================

2.1. Data processing {#jcp29255-sec-0030}
--------------------

The gene‐expression profile GSE45765 provided by Gysin et al (<https://www.gcbi.com.cn/gcbi/dataplus/html/details?acc=GSE45765&keywords=GSE45765>) was obtained from the Gene Expression Omnibus (GEO) database. Eight PDA cell samples were thereafter downloaded with or without MEK1/2 inhibition. The raw files were processed with robust multiarray average (RMA) algorithm. The nsFilter algorithm was used to filter the data for the subsequent WGCNA. All data used for Kaplan--Meier survival analysis were obtained from TCGA (<https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga>). The clinical features of patients from TCGA are provided in the Supporting Information, and Kaplan--Meier survival analysis was performed based on TCGA.

2.2. Patients and tissue specimens {#jcp29255-sec-0040}
----------------------------------

Patients with PDA were enrolled at the Affiliated Hospital of Nantong University and Qidong People\'s Hospital from 2016 to 2018. PDA tissue samples were frozen in liquid nitrogen. Approaches used in the study were approved by the Ethics Committee (No. 2013 \[22\]) of Nantong University and conformed with the *Ethical Guidelines of the 1975 Declaration of Helsinki* (6th revision, 2008) and government policies.

2.3. Cell lines and culture conditions {#jcp29255-sec-0050}
--------------------------------------

PaCa‐2 and Panc‐1 were cultured in an incubator (37°C, 5% CO~2~) and in RPMI 1640 (Gibco) supplemented with 10% fetal bovine serum (Gibco). PDA cells were treated by CI‐1040 following literature \[Huang et al., [2018](#jcp29255-bib-0009){ref-type="ref"}\].

2.4. Cell transfection {#jcp29255-sec-0060}
----------------------

siRNA‐MEK1 and siRNA‐MEK2 were transfected into PaCa‐2 and Panc‐1. The empty vector functioned as a negative control. Lipofectamine 2000 (Invitrogen) was used for the transfection according to the official instructions.

2.5. Quantitative reverse‐transcription polymerase chain reaction {#jcp29255-sec-0070}
-----------------------------------------------------------------

All RNAs were isolated using TRIzol Reagent (Life Technologies). SYBR Green qRT‐PCR on an ABI7300 real‐time PCR machine was used to measure the expression levels of mRNAs. B4GALT6B4GALT6 and β‐actin expression were examined using the following specific primers: 5′CGGATGATGCGGGTTTCCAA3′, 5′ACCGTTGAGCGTACTGTTTTTA3′, 5′GGACTTCGAGCAAGAGATGG3′, and 5′AGCACTGTGTTGGCGTACAG3′.

2.6. Establishment of weighted gene coexpression networks and identification of modules {#jcp29255-sec-0080}
---------------------------------------------------------------------------------------

lncRNA--mRNA coexpression networks and modules were constructed according to literature (Yin, Cai, Zhu, & Xu, [2018](#jcp29255-bib-0029){ref-type="ref"}). WGCNA is a freely accessible R package for the construction of weighted lncRNA--mRNA coexpression networks. In the present research, a one‐step function was performed to construct network and detect consensus modules.

2.7. Interaction analysis of coexpression modules {#jcp29255-sec-0090}
-------------------------------------------------

The interaction analysis of coexpression modules was performed following literature (Wang, Xu et al., [2018](#jcp29255-bib-0025){ref-type="ref"}). We calculated the eigengene adjacency, which was based on similar coexpression in modules. The specific interaction relationship among different modules was processed through flashClust function. A heat map was established to show the correlations of different modules.

2.8. GO function and KEGG pathway analyses {#jcp29255-sec-0100}
------------------------------------------

GO function and KEGG pathway analyses were performed following literature (Wang, Xu et al., [2018](#jcp29255-bib-0025){ref-type="ref"}). GO function and KEGG pathway analyses were performed using discovery (DAVID) and KOBAS 3.0. R language ggplot2 package was used to process the enrichment results of visualization figures.

3. RESULTS {#jcp29255-sec-0110}
==========

3.1. Data of GSE4576 processing {#jcp29255-sec-0120}
-------------------------------

Eight PDA cell sample raw files were obtained from NCBI (<https://www.ncbi.nlm.nih.gov/pubmed/>). The expression profiles by an array of GSE4576 were converted to expression data, which was handled with the RMA algorithm. Specifically, the RMA algorithm included background correction, normalization, and summarization based on R language programming. The differently expressed mRNAs and lncRNAs are listed in the Supporting Information.

3.2. Establishing weighted lncRNA--mRNA coexpression networks and identification of soft threshold power {#jcp29255-sec-0130}
--------------------------------------------------------------------------------------------------------

A lncRNA--mRNA coexpression network was established from the sample raw files, and different modules were established. Soft threshold power 18 was used to define the adjacency matrix, which was processed with the criteria of approximate scale‐free topology (Figure [1](#jcp29255-fig-0001){ref-type="fig"}).

![Freedom relative weight choice about coexpression modules. Numbers in the plots show the corresponding soft thresholding powers. The approximate freedom relative weight choice can be attained at the soft thresholding power of 18](JCP-235-3657-g001){#jcp29255-fig-0001}

3.3. Correlation among different modules {#jcp29255-sec-0140}
----------------------------------------

A dendrogram of bioinformatics analysis based on GSE45765 is shown in Figure [2](#jcp29255-fig-0002){ref-type="fig"}a. Dendrogram clusters and heat maps are shown in Figure [2](#jcp29255-fig-0002){ref-type="fig"}b,c. The minimum module size was 10, the module detection sensitivity deepSplit was 2, and the cut height for merging of modules was 0.2, indicating that the modules whose eigengenes were correlated above 0.8 will be merged. Combined with Figure [3](#jcp29255-fig-0003){ref-type="fig"}, various modules related to MEK/ERK signaling were found. For example, green, black, red, turquoise, pink, yellow, and blue modules were related to MEK1/2 inhibition. Specifically, the red module meant intense relation to insensitive cells and black meant strong relation to sensitive cells.

![lncRNA and mRNA coexpression modules identified by WGCNA. (a) Dendrogram of bioinformatics analysis based on GSE45765. (b) Dendrogram obtained by clustering the dissimilarity based on consensus topological overlap with the corresponding module colors indicated by the color row. (c) Eigengene adjacencies of heat map. Red shows high adjacency and blue shows low adjacency. lncRNA, long noncoding RNA; mRNA, messenger RNA; WGCNA, weighted gene coexpression network analysis](JCP-235-3657-g002){#jcp29255-fig-0002}

![Relationships of consensus module‐trait in lncRNA and mRNA coexpression modules. According to the corresponding color legend, the table was color‐coded to show the correlation. Specifically, red showed a positive correlation and blue showed a negative correlation. The corresponding numbers in squares showed the correlation between the module stage and eigengenes. The corresponding *p* values are shown below in parentheses. lncRNA, long noncoding RNA; mRNA, messenger RNA](JCP-235-3657-g003){#jcp29255-fig-0003}

3.4. GO function and KEGG pathway analyses {#jcp29255-sec-0150}
------------------------------------------

Based on differently expressed mRNAs, GO function and KEGG pathway analysis were performed (Figures [4](#jcp29255-fig-0004){ref-type="fig"} and [5](#jcp29255-fig-0005){ref-type="fig"}). GO function analysis indicated that differently expressed mRNAs were enriched during tumor progression. For example, blue module meant enrichment in function on cell migration, red module meant enrichment in function on proliferation, and turquoise module meant enrichment in function on cell apoptosis (Figure [4](#jcp29255-fig-0004){ref-type="fig"}). Similarly, KEGG pathway analysis showed that MEK/ERK‐related pathways and other vital cancer pathways were enriched. For example, Ras and MAPK pathways were enriched isun turquoise, blue, and red modules. PI3K‐AKT pathway was enriched in turquoise, blue, brown, red, and black modules (Figure [5](#jcp29255-fig-0005){ref-type="fig"}).

![Result of GO analysis about mRNA based on WGCNA**.** The vertical axis shows the results of the GO analysis and the horizontal axis shows the different modules. The color of the round shape shows transitional values (log10 of q value), and the size shows the number of genes that were enriched. Go, Gene ontology; mRNA, messenger RNA; WGCNA, weighted gene coexpression network analysis](JCP-235-3657-g004){#jcp29255-fig-0004}

![Result of pathway analysis about mRNA based on WGCNA. The vertical axis shows the results of pathway analysis and the horizontal axis shows the different modules. The color of the round shape shows transitional values (log10 of q value), and the size shows the number of genes that were enriched. mRNA, messenger RNA; WGCNA, weighted gene coexpression network analysis](JCP-235-3657-g005){#jcp29255-fig-0005}

3.5. Construction of lncRNA--mRNA network and lncRNA--mRNA pathway {#jcp29255-sec-0160}
------------------------------------------------------------------

Using GSE45765 data, lncRNA and mRNA coexpress networks were established based on the WGCNA method. The selection results of differently expressed lncRNAs and mRNA are shown in Tables [1](#jcp29255-tbl-0001){ref-type="table"} and [2](#jcp29255-tbl-0002){ref-type="table"}. The lncRNA--mRNA network in black (a), red (b), and turquoise (c) modules are shown in Figure [6](#jcp29255-fig-0006){ref-type="fig"}a--c, and the lncRNA--mRNA pathway in black (d), red (e), and turquoise (f) are shown in Figure [6](#jcp29255-fig-0006){ref-type="fig"}d--f. lncRNA and mRNA coexpression networks were enriched in the pathway related to MEK/ERK pathway signaling and in multiple‐cancer pathway signaling. For example, RAS pathway signaling and MAPK pathway signaling was strongly correlated with MEK/ERK pathway signaling (Diamond et al., [2019](#jcp29255-bib-0003){ref-type="ref"}; Xie et al., [2019](#jcp29255-bib-0026){ref-type="ref"}). Rap1 pathway, PI3K/AKT pathway, and JAK/STAT pathway were closely related to cancer progression (Hamidi & Ivaska, [2018](#jcp29255-bib-0008){ref-type="ref"}). These results suggested that MEK1/2 was a central location in progression of PDA and can thus contribute to investigating the potential relationship between MEK/ERK pathway signaling and other multiple cancer‐related pathways.

###### 

The result of lncRNA--mRNA pathway about differently expressed lncRNAs

  Module      lncRNA              Style   *p*
  ----------- ------------------- ------- -------
  Turquoise   NONHSAT185150.1     Up      .012
  Turquoise   NR_136202.1         Up      .018
  Turquoise   NONHSAT033101.2     Up      .043
  Red         ENST00000381105.2   Down    .023
  Red         ENST00000614781.1   Up      .0081
  Red         NONHSAT108374.2     Up      .0029
  Black       NONHSAT040789.2     Down    .031
  Black       ENST00000633336.1   Up      .020
  Black       NONHSAT097188.2     Up      .026

Abbreviations: lncRNA, long noncoding RNA; mRNA, messenger RNA.

John Wiley & Sons, Ltd.

###### 

The part result of lncRNA--mRNA pathway about differently expressed mRNA

  Module      mRNA      Style   *p*
  ----------- --------- ------- --------
  Turquoise   CXCL3     Up      .00052
  Turquoise   CDC6      Down    .0014
  Turquoise   FAXDC2    Up      .0069
  Black       B4GALT6   Down    .038
  Black       MPDZ      Up      .021
  Black       AMY1A     Up      .00052
  Red         DAPK1     Up      .0089
  Red         INPP5B    Down    .042
  Red         LAMA3     Up      .0046

Abbreviations: lncRNA, long noncoding RNA; mRNA, messenger RNA.

John Wiley & Sons, Ltd.

![Established lncRNA--mRNA network and lncRNA--mRNA pathway. (a--c) lncRNA--mRNA network of genes in black (a), red (b), and turquoise (c) modules. (d--f) lncRNA--mRNA pathway of genes in black (d), red (e), and turquoise (f) modules](JCP-235-3657-g006){#jcp29255-fig-0006}

3.6. Kaplan--Meier survival analysis {#jcp29255-sec-0170}
------------------------------------

MEK1/2 was negatively correlated with the overall survival of PDA. Based on TCGA, Kaplan--Meier survival analysis was used to determine the relationship of the expression levels of lncRNAs and genes with the survival time of PDA. The survival data was provided in the Supporting Information. As shown in Figure [7](#jcp29255-fig-0007){ref-type="fig"}, NONHSAT185150.1 and NONHSAT083938.2 were positively correlated with the overall survival of PDA (Figure [7](#jcp29255-fig-0007){ref-type="fig"}a,b). Moreover, B4GALT6, MPDZ, and INPP5B were positively correlated with the overall survival of PDA (Figure [7](#jcp29255-fig-0007){ref-type="fig"}c--f). DAPK1 and LAMA3 were negatively correlated with the overall survival of PDA (Figure [7](#jcp29255-fig-0007){ref-type="fig"}f,g). Thus, above lncRNAs and mRNA may play important roles in MEK/ERK pathway signaling and can be prognostic markers for PDA.

![Kaplan--Meier survival analysis of lncRNAs and genes. (a, b) High NONHSAT185150.1 and NONHSAT083938.2 expression were significantly associated positively with OS in PDA. (c--e) High B4GALT6, MPDZ, and INPP5B expression were positively associated with OS in PDA. (f, g) High DAPK1 and LAMA3 were negatively associated with OS in PDA. lncRNA, long noncoding RNA; OS, overall survival; PDA, pancreatic ductal adenocarcinoma](JCP-235-3657-g007){#jcp29255-fig-0007}

3.7. The expression levels of NONHSAT185150.1 and B4GALT6 were negatively correlated with MEK1/2 {#jcp29255-sec-0180}
------------------------------------------------------------------------------------------------

To validate the results of coexpression network, qPCR was performed. Results indicated that NONHSAT185150.1 expression levels were upregulated in PaCa‐2 and Panc‐1 treated by CI‐1040 (Figure [8](#jcp29255-fig-0008){ref-type="fig"}a,b). Similarly, B4GALT6 expression levels were upregulated in PDA treated by CI‐1040 (Figure [8](#jcp29255-fig-0008){ref-type="fig"}c,d). Moreover, western blot results indicated that the protein expression levels of B4GALT6 were upregulated in PDA cells treated by CI‐1040 (Figure [8](#jcp29255-fig-0008){ref-type="fig"}e). According to the expression level of MEK1/2, PDA tissues were divided into two groups. qPCR results indicated that NONHSAT185150.1 expression level was negatively correlated with MEK1/2 in PDA tissues (Figures [8](#jcp29255-fig-0008){ref-type="fig"}f,g), and the B4GALT6 expression level was negatively correlated to MEK1/2 in PDA tissues (Figure [8](#jcp29255-fig-0008){ref-type="fig"}h,i).

![The expression level of NONHSAT185150.1 and B4GALT6 was negatively correlated with MEK1/2. (a, b) The expression level of NONHSAT185150.1 was upregulated after MEK1/2 inhibition in PAD cells. (c, d) The expression level of B4GALT6 was upregulated after MEK1/2 inhibition in PAD cells. (e) Western blot results indicated that the protein expression levels of B4GALT6 were upregulated in PDA cells treated by CI‐1040. (f, g) The expression level of NONHSAT185150.1 was negatively correlated with MEK1/2 in PAD tissues. (h, i) The expression level of B4GALT6 was negatively correlated with MEK1/2 in PAD tissues](JCP-235-3657-g008){#jcp29255-fig-0008}

4. DISCUSSION {#jcp29255-sec-0190}
=============

Early‐stage diagnostic markers and effective drugs for PDA are unavailable, so the molecular mechanism of PDA progression needs to be understood. The MEK/ERK pathway has been recently considered as a breakthrough point in PDA. The new drug targeting this pathway has been subjected to clinical experiments (Jiang et al., [2018](#jcp29255-bib-0011){ref-type="ref"}). lncRNAs are important regulators of gene expression and play vital roles in cancer. HOXD‐AS1 upregulates the expression of PIK3R3 by competing endogenous RNAs in ovarian cancer (Dong et al., [2019](#jcp29255-bib-0004){ref-type="ref"}). A positive feedback loop exists between HOTAIR and EZH2 in prostate cancer (Ling et al., [2017](#jcp29255-bib-0015){ref-type="ref"}). The lncRNA--mRNA network has provided a new angle to understand cancer‐related pathways (Jia et al., [2019](#jcp29255-bib-0010){ref-type="ref"}). In the present study, the lncRNA--mRNA network after MEK1/2 inhibition was established based on WGCNA.

GSE45765, which is the genome‐wide profile after MEK1/2 inhibition, was initially obtained from GEO. Differently expressed lncRNAs and mRNAs were found and 10 modules were identified based on WGCNA. The relationship among consensus module traits were then studied. Many modules showed strong relevance after MEK1/2 inhibition. Specifically, the red module was intensely correlated with insensitive cells and black was strongly correlated with sensitive cells. Moreover, GO and pathway analyses were performed based on differently expressed genes. Interestingly, the analysis results included the MEK/ERK1‐related pathway (RAS and MAPK pathways) and many other cancer‐related pathways (FoxO and mTOR pathways). All these results suggested that MEK1/2 may be the trigger in various pathways. Moreover, the lncRNA--mRNA network and lncRNA--mRNA pathway network were established. Nine new lncRNAs were identified in selected modules. lncRNAs can upregulate or downregulate gene expression in several manners (Gao et al., [2019](#jcp29255-bib-0005){ref-type="ref"}). A total of 44 coexpressed mRNA were identified. For instance, DAPK1, CDH2, WNT4, and RSAD2 are downstream signaling molecules of the MEK/ERK pathway (Civiero, Dihanich, Lewis, & Greggio, [2014](#jcp29255-bib-0002){ref-type="ref"}; Su, Li, Shi, Hruban, & Radice, [2016](#jcp29255-bib-0019){ref-type="ref"}). ASS1, CDKN2A, and RAC3 also play important roles in PDA progression (Lowery et al., [2017](#jcp29255-bib-0016){ref-type="ref"}). Apart from the MEK/ERK‐related pathways such as 1 and 2, other cancer‐related pathways exist in the network. Thus, the lncRNA--mRNA pathway network can help investigate the roles of MEK1/2 in the regulatory network in PDA. Finally, PDA cells and tissues were used to validate the coexpression network. After treatment with CI‐1040, qRCR results showed that NONHSAT185150.1 expression levels were upregulated in PaCa‐2 and Panc‐1. Similarly, B4GALT6 mRNA expression levels were upregulated in PaCa‐2 and Panc‐1. PDA tissues (*n* = 60) were further divided into two groups following the B4GALT6 expression level. qPCR results indicated that the expression levels of NONHSAT185150.1 and B4GALT6 were negatively related to the MEK1/2 expression level.

In conclusion, this study presented a lncRNA--mRNA network after MEK1/2 inhibition at the genome level based on WGCNA. Ten modules were identified using WGCNA. GO and pathway analyses were performed based on differently expressed genes. Furthermore, lncRNA--mRNA network and lncRNA--mRNA pathway network were established in three selected modules. qPCR results indicated that NONHSAT185150.1 and B4GALT6 were negatively correlated with MEK1/2 expression level in PDA cells and tissues. Overall, our study can help explore the MEK/ERK pathway and study the drug targeting of MEK1/2.
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